US Broker Ratings

Bausch + Lomb Corporation (BLCO) Stock Analysis: Examining a Healthcare Leader with 11.68% Potential Upside

Bausch + Lomb Corporation (NYSE: BLCO) stands as a stalwart in the healthcare sector, specializing in medical instruments and supplies. With a rich history dating back to 1853, the company..

Encompass Health Corporation (EHC) Stock Analysis: A Compelling 27.54% Upside Potential

Encompass Health Corporation (NYSE: EHC), a leading player in the healthcare sector, specifically in medical care facilities, is drawing significant attention from investors due to its robust growth potential and..

RadNet, Inc. (RDNT) Stock Analysis: A Compelling 36.81% Potential Upside for Investors

RadNet, Inc. (NASDAQ: RDNT), a prominent player in the healthcare sector, specifically in diagnostics and research, presents a promising opportunity for investors seeking growth in the medical imaging industry. With..

West Pharmaceutical Services (WST) Stock Analysis: A Healthcare Giant with a 21% Revenue Growth and Solid Analyst Ratings

West Pharmaceutical Services, Inc. (NYSE: WST) stands as a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry. With a substantial market capitalization of $24.99..

Elanco Animal Health (ELAN) Stock Analysis: Analyst Consensus Signals 20% Upside Potential

Elanco Animal Health Incorporated (NYSE: ELAN) stands as a prominent player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With a market capitalization of $12.4..

Tenet Healthcare Corporation (THC) Stock Analysis: A Healthcare Giant with Strong Buy Ratings and 19.55% Upside Potential

Tenet Healthcare Corporation (NYSE: THC), a stalwart in the healthcare sector, is making waves with its robust position in the medical care facilities industry. With a market capitalization of $17.59..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: Navigating a 22% Potential Upside in the Medical Devices Sector

GE HealthCare Technologies Inc. (NYSE: GEHC), a stalwart in the healthcare sector, particularly within the medical devices industry, presents an intriguing opportunity for investors seeking growth and stability. With a..

Revolution Medicines, Inc. (RVMD) Stock Analysis: A Biotech Titan with a Promising 7.17% Upside

Revolution Medicines, Inc. (NASDAQ: RVMD) stands out in the biotechnology landscape, driven by its pioneering approach to developing targeted therapies for RAS-addicted cancers. The company’s robust portfolio and strategic positioning..

Roivant Sciences Ltd. (ROIV) Stock Analysis: Exploring the 9.47% Upside Potential in Biotech Innovation

Roivant Sciences Ltd. (NASDAQ: ROIV), a trailblazer in the biotechnology industry, is captivating investor attention with its robust pipeline and a promising potential upside of 9.47%. Based in London, this..

BioNTech SE (BNTX) Stock Analysis: Navigating a 33% Upside Potential Amidst Revenue Challenges

In the ever-evolving biotechnology sector, BioNTech SE (NASDAQ: BNTX) presents a compelling investment case with its diverse portfolio of immunotherapies and a significant potential upside of 33.08%. Based in Mainz,..

Summit Therapeutics Inc. (SMMT) Stock Analysis: Exploring an 87.99% Potential Upside in Biotechnology

Summit Therapeutics Inc. (NASDAQ: SMMT), a prominent player in the biotechnology sector, offers investors a combination of potential high reward and significant risk. With a market capitalization of $11.84 billion,..

Charles River Laboratories (CRL) Stock Analysis: Navigating Growth Amidst a Challenging Valuation Landscape

Charles River Laboratories International, Inc. (NYSE: CRL) stands as a key player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $11.24 billion,..

Jazz Pharmaceuticals plc (JAZZ) Stock Analysis: Strong Buy Ratings and Potential Upside Amid Robust Revenue Growth

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is a prominent player in the biotechnology sector, making waves with its innovative pharmaceutical products and promising pipeline. Headquartered in Dublin, Ireland, the company has..

Biogen Inc. (BIIB) Stock Analysis: Navigating a Robust Pipeline with 11.89% Upside Potential

Biogen Inc. (NASDAQ: BIIB) stands as a towering figure in the healthcare sector, with its extensive portfolio of therapies spanning multiple sclerosis, neurological diseases, and other complex conditions. As of..

ResMed Inc. (RMD) Stock Analysis: Navigating a 25.60% Potential Upside Amidst Strong Healthcare Sector Growth

ResMed Inc. (NYSE: RMD), a significant player in the healthcare sector, stands at the forefront of the medical instruments and supplies industry with a market capitalization of $29.57 billion. The..

TG Therapeutics, Inc. (TGTX) Stock Analysis: A Healthcare Standout with Robust Revenue Growth

TG Therapeutics, Inc. (NASDAQ: TGTX) has emerged as a noteworthy player in the healthcare sector, specifically in the biotechnology industry. With a market capitalization of $8.74 billion, this American company..

Revvity, Inc. (RVTY) Stock Analysis: Navigating Growth with a 7% Revenue Rise and Analyst Insights

Revvity, Inc. (NASDAQ: RVTY), a prominent player in the healthcare sector specializing in diagnostics and research, has been making waves with its recent financial performance and market movements. With a..

Exelixis, Inc. (EXEL) Stock Analysis: Navigating Growth in the Oncology Biotech Space

Exelixis, Inc. (EXEL), a prominent player in the biotech sector with a focus on oncology, has been making waves with its innovative cancer treatments. With a market capitalization of $14.2..

BrightSpring Health Services, I (BTSG): Investor Outlook Amid Strong Revenue Growth and Robust Analyst Ratings

BrightSpring Health Services, Inc. (NASDAQ: BTSG) is making waves in the healthcare sector with its notable market presence and promising growth trajectory. As a premier provider of home and community-based..

Atrium Therapeutics, Inc. (RNA) Stock Analysis: A 100.64% Potential Upside in RNA Therapeutics

Atrium Therapeutics, Inc. (NASDAQ: RNA) is drawing significant attention from investors in the biotechnology sector, particularly due to its staggering potential upside of over 100%. This San Diego-based biopharmaceutical company..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds